Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine

Por Jaeckle, K A, Phuphanich, S, Bent, M J van den, Aiken, R, Batchelor, T, Campbell, T, Fulton, D, Gilbert, M, Heros, D, Rogers, L, O'Day, S J, Akerley, W, Allen, J, Baidas, S, Gertler, S Z, Greenberg, H S, LaFollette, S, Lesser, G, Mason, W, Recht, L, Wong, E, Chamberlain, M C, Cohn, A, Glantz, M J, Gutheil, J C, Maria, B, Moots, P, New, P, Russell, C, Shapiro, W, Swinnen, L, Howell, S B
Publicado em 2001

Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205

Por Li, T., Christos, P. J., Sparano, J. A., Hershman, D. L., Hoschander, S., O'Brien, K., Wright, J. J., Vahdat, L. T.
Publicado em 2009

Activity of a new nitrosourea (TCNU) in human lung cancer xenografts.

Por Fergusson, R. J., Anderson, L. E., Macpherson, J. S., Robins, P., Smyth, J. F.
Publicado em 1988

Cost effectiveness of a new strategy to identify HNPCC patients

Por Kievit, W, de Bruin, J H F M, Adang, E M M, Severens, J L, Kleibeuker, J H, Sijmons, R H, Ruers, T J, Nagengast, F M, Vasen, H F A, van Krieken, J H J M, Ligtenberg, M J L, Hoogerbrugge, N
Publicado em 2005

New Approaches to the Treatment of Advanced Prostate Cancer

Por Goluboff, Erik T, Hirano, Daisaku, Thrasher, J Brantley, Stark, George, Miller, Gary J, Glodé, L Michael
Publicado em 2001

Comparing the performance of six human papillomavirus tests in a screening population

Por Cuzick, J, Cadman, L, Mesher, D, Austin, J, Ashdown-Barr, L, Ho, L, Terry, G, Liddle, S, Wright, C, Lyons, D, Szarewski, A
Publicado em 2013

Changing Pattern of Esophageal Cancer Incidence in New Mexico: A 30-Year Evaluation

Por Vega, Kenneth J., Jamal, M. Mazen, Wiggins, Charles L.
Publicado em 2009

Proton beam therapy and localised prostate cancer: current status and controversies

Por Efstathiou, J A, Gray, P J, Zietman, A L
Publicado em 2013

Computed tomography–quantified body composition predicts short-term outcomes after gastrectomy in gastric cancer

Por Zhang, Y., Wang, J.P., Wang, X.L., Tian, H., Gao, T.T., Tang, L.M., Tian, F., Wang, J.W., Zheng, H.J., Zhang, L., Gao, X.J., Li, G.L., Wang, X.Y.
Publicado no Curr Oncol (2018)

Prayer and Self-Reported Health Among Cancer Survivors in the United States, National Health Interview Survey, 2002

Por Ross, Louie E., Hall, Ingrid J., Fairley, Temeika L., Taylor, Yhenneko J., Howard, Daniel L.
Publicado em 2008

Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York

Por Varma, G, Varma, R, Huang, H, Pryshchepava, A, Groth, J, Fleming, D, Nowak, N J, McQuaid, D, Conroy, J, Mahoney, M, Moysich, K, Falkner, K L, Geradts, J
Publicado em 2005

Increased risk for lung cancer and for cancer of the gastrointestinal tract among Geneva professional drivers.

Por Gubéran, E, Usel, M, Raymond, L, Bolay, J, Fioretta, G, Puissant, J
Publicado em 1992

Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders

Por Heal, David J, Gosden, Jane, Smith, Sharon L
Publicado em 2009

Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients

Por Baas, J. M., Krens, L. L., ten Tije, A. J., Erdkamp, F., van Wezel, T., Morreau, H., Gelderblom, H., Guchelaar, H. J.
Publicado no Invest New Drugs (2015)

Risk of new primary cancer in patients with oropharyngeal cancer.

Por Söderholm, A. L., Pukkala, E., Lindqvist, C., Teppo, L.
Publicado em 1994

Current Role of Surgery in the Management of Oropharyngeal Cancer

Por Turner, Meghan T., Byrd, J. Kenneth, Ferris, Robert L.
Publicado no J Oncol Pract (2016)

Cost-effectiveness of oxaliplatin in the adjuvant treatment of colon cancer in Canada

Por Attard, C.L., Maroun, J.A., Alloul, K., Grima, D.T., Bernard, L.M.
Publicado em 2010

False-positive screening results in the Finnish prostate cancer screening trial

Por Kilpeläinen, T P, Tammela, T L J, Määttänen, L, Kujala, P, Stenman, U-H, Ala-Opas, M, Murtola, T J, Auvinen, A
Publicado em 2010

A new tumor suppressor lncRNA RP11-190D6.2 inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells

Por Tong W, Yang L, Yu Q, Yao J, He A
Publicado em 2017-02-01

Impact of New Chemotherapeutic and Targeted Agents on Survival in Stage IV Non-Small Cell Lung Cancer

Por Yu, Joanne L., Simmons, Christine, Victor, J. Charles, Han, Dolly, Hogeveen, Sophie, Leighl, Natasha, Verma, Sunil
Publicado em 2011